Literature DB >> 30797773

Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo.

Adan Codina1, Paul A Renauer1, Guangchuan Wang2, Ryan D Chow3, Jonathan J Park3, Hanghui Ye2, Kerou Zhang4, Matthew B Dong3, Brandon Gassaway5, Lupeng Ye2, Youssef Errami2, Li Shen2, Alan Chang2, Dhanpat Jain6, Roy S Herbst7, Marcus Bosenberg8, Jesse Rinehart5, Rong Fan4, Sidi Chen9.   

Abstract

The genetic makeup of cancer cells directs oncogenesis and influences the tumor microenvironment. In this study, we massively profiled genes that functionally drive tumorigenesis using genome-scale in vivo CRISPR screens in hosts with different levels of immunocompetence. As a convergent hit from these screens, Prkar1a mutant cells are able to robustly outgrow as tumors in fully immunocompetent hosts. Functional interrogation showed that Prkar1a loss greatly altered the transcriptome and proteome involved in inflammatory and immune responses as well as extracellular protein production. Single-cell transcriptomic profiling and flow cytometry analysis mapped the tumor microenvironment of Prkar1a mutant tumors and revealed the transcriptomic alterations in host myeloid cells. Taken together, our data suggest that tumor-intrinsic mutations in Prkar1a lead to drastic alterations in the genetic program of cancer cells, thereby remodeling the tumor microenvironment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Prkar1a; cancer genomics; cancer immunology; in vivo CRISPR screen; transformation

Mesh:

Year:  2019        PMID: 30797773      PMCID: PMC6592847          DOI: 10.1016/j.cels.2019.01.004

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  62 in total

1.  Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer.

Authors:  Kristin J Lastwika; Willie Wilson; Qing Kay Li; Jeffrey Norris; Haiying Xu; Sharon R Ghazarian; Hiroshi Kitagawa; Shigeru Kawabata; Janis M Taube; Sheng Yao; Linda N Liu; Joell J Gills; Phillip A Dennis
Journal:  Cancer Res       Date:  2015-12-04       Impact factor: 12.701

2.  An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets.

Authors:  Daniel Schwartz; Steven P Gygi
Journal:  Nat Biotechnol       Date:  2005-11       Impact factor: 54.908

Review 3.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

4.  Correction of aberrant growth preserves tissue homeostasis.

Authors:  Samara Brown; Cristiana M Pineda; Tianchi Xin; Jonathan Boucher; Kathleen C Suozzi; Sangbum Park; Catherine Matte-Martone; David G Gonzalez; Julie Rytlewski; Slobodan Beronja; Valentina Greco
Journal:  Nature       Date:  2017-08-02       Impact factor: 49.962

5.  Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.

Authors:  Rondell P Graham; Carolin Lackner; Luigi Terracciano; Yessica González-Cantú; Joseph J Maleszewski; Patricia T Greipp; Sanford M Simon; Michael S Torbenson
Journal:  Hepatology       Date:  2018-05-11       Impact factor: 17.425

6.  Identification of essential genes for cancer immunotherapy.

Authors:  Shashank J Patel; Neville E Sanjana; Rigel J Kishton; Arash Eidizadeh; Suman K Vodnala; Maggie Cam; Jared J Gartner; Li Jia; Seth M Steinberg; Tori N Yamamoto; Anand S Merchant; Gautam U Mehta; Anna Chichura; Ophir Shalem; Eric Tran; Robert Eil; Madhusudhanan Sukumar; Eva Perez Guijarro; Chi-Ping Day; Paul Robbins; Steve Feldman; Glenn Merlino; Feng Zhang; Nicholas P Restifo
Journal:  Nature       Date:  2017-08-07       Impact factor: 49.962

7.  Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity.

Authors:  R Dixon Dorand; Joseph Nthale; Jay T Myers; Deborah S Barkauskas; Stefanie Avril; Steven M Chirieleison; Tej K Pareek; Derek W Abbott; Duncan S Stearns; John J Letterio; Alex Y Huang; Agne Petrosiute
Journal:  Science       Date:  2016-07-21       Impact factor: 47.728

Review 8.  Familial pituitary tumors.

Authors:  Neda Alband; Márta Korbonits
Journal:  Handb Clin Neurol       Date:  2014

9.  Integrating single-cell transcriptomic data across different conditions, technologies, and species.

Authors:  Andrew Butler; Paul Hoffman; Peter Smibert; Efthymia Papalexi; Rahul Satija
Journal:  Nat Biotechnol       Date:  2018-04-02       Impact factor: 54.908

10.  Lineage-specific biology revealed by a finished genome assembly of the mouse.

Authors:  Deanna M Church; Leo Goodstadt; Ladeana W Hillier; Michael C Zody; Steve Goldstein; Xinwe She; Carol J Bult; Richa Agarwala; Joshua L Cherry; Michael DiCuccio; Wratko Hlavina; Yuri Kapustin; Peter Meric; Donna Maglott; Zoë Birtle; Ana C Marques; Tina Graves; Shiguo Zhou; Brian Teague; Konstantinos Potamousis; Christopher Churas; Michael Place; Jill Herschleb; Ron Runnheim; Daniel Forrest; James Amos-Landgraf; David C Schwartz; Ze Cheng; Kerstin Lindblad-Toh; Evan E Eichler; Chris P Ponting
Journal:  PLoS Biol       Date:  2009-05-26       Impact factor: 8.029

View more
  3 in total

Review 1.  Tumor immunology CRISPR screening: present, past, and future.

Authors:  Matthew B Dong; Kaiyuan Tang; Xiaoyu Zhou; Jingjia J Zhou; Sidi Chen
Journal:  Trends Cancer       Date:  2021-12-15

2.  In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.

Authors:  Xiaoqing Wang; Collin Tokheim; Shengqing Stan Gu; Binbin Wang; Qin Tang; Yihao Li; Nicole Traugh; Zexian Zeng; Yi Zhang; Ziyi Li; Boning Zhang; Jingxin Fu; Tengfei Xiao; Wei Li; Clifford A Meyer; Jun Chu; Peng Jiang; Paloma Cejas; Klothilda Lim; Henry Long; Myles Brown; X Shirley Liu
Journal:  Cell       Date:  2021-09-27       Impact factor: 66.850

3.  Complex effects of kinase localization revealed by compartment-specific regulation of protein kinase A activity.

Authors:  Rebecca LaCroix; Benjamin Lin; Tae-Yun Kang; Andre Levchenko
Journal:  Elife       Date:  2022-02-24       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.